Sign in
4

Changes in Ownership

TScan Therapeutics, Inc. Filed Acc 0000950170-25-018130

Options or other derivatives

  • Vice President, Finance acquired 46,875 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Dworak Leiden Vice President, Finance 2024-01-12 Grant or award · Stock Option (Right to Buy) +46,875 46,875 D
Loading xslF345X05/ownership.xml…